Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease

Experimental Neurology

Volumn 239, Issue 1, 2013, Pages 28-37

  Beauquis, Juan ^a,b   Pavía, Patricio ^a   Pomilio, Carlos ^a   Vinuesa, Angeles ^a   Podlutskaya, Natalia ^c   Galvan, Verónica ^c   Saravia, Flavia ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Alzheimer's disease; Astrocytes; Environmental enrichment; GFAP; Hippocampus; Transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL POPULATION; CELL STRUCTURE; CELL VOLUME; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; ENVIRONMENTAL ENRICHMENT; FEMALE; HIPPOCAMPUS; MOUSE; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SHOLL ANALYSIS; THREE DIMENSIONAL IMAGING; TRANSGENIC MOUSE; TREATMENT DURATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; BRAIN CHEMISTRY; COLORING AGENTS; CONGO RED; DISEASE PROGRESSION; ENVIRONMENT; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID;

EID: 84867775830     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.09.009     Document Type: Article

References (84)

1. Abramoff M.D., Magelhaes P.J., Ram S.J. Image processing with ImageJ. Biophotonics Int. 2004, 11:36-42.
2. Akiyama H., Mori H., Saido T., Kondo H., Ikeda K., McGeer P.L. Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease. Glia 1999, 25:324-331.
3. Arendash G.W., Garcia M.F., Costa D.A., Cracchiolo J.R., Wefes I.M., Potter H. Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport 2004, 15:1751-1754.
4. Arranz L., De Castro N.M., Baeza I., Gimenez-Llort L., la FM De Effect of environmental enrichment on the immunoendocrine aging of male and female triple-transgenic 3xTg-AD mice for Alzheimer's disease. J. Alzheimers Dis. 2011, 25:727-737.
5. Beach T.G., Walker R., McGeer E.G. Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 1989, 2:420-436.
6. Beauquis J., Roig P., De Nicola A.F., Saravia F. Short-term environmental enrichment enhances adult neurogenesis, vascular network and dendritic complexity in the hippocampus of type 1 diabetic mice. PLoS One 2010, 5:e13993.
7. Benediktsson A.M., Schachtele S.J., Green S.H., Dailey M.E. Ballistic labeling and dynamic imaging of astrocytes in organotypic hippocampal slice cultures. J. Neurosci. Methods 2005, 141:41-53.
8. Bindu B., Alladi P.A., Mansooralikhan B.M., Srikumar B.N., Raju T.R., Kutty B.M. Short-term exposure to an enriched environment enhances dendritic branching but not brain-derived neurotrophic factor expression in the hippocampus of rats with ventral subicular lesions. Neuroscience 2007, 144:412-423.
9. Boekhoorn K., Joels M., Lucassen P.J. Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol. Dis. 2006, 24:1-14.
10. Braak H., Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural Transm. Suppl. 1998, 53:127-140.
11. Briones T.L., Rogozinska M., Woods J. Environmental experience modulates ischemia-induced amyloidogenesis and enhances functional recovery. J. Neurotrauma 2009, 26:613-625.
12. Carter S.F., Scholl M., Almkvist O., Wall A., Engler H., Langstrom B., Nordberg A. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J. Nucl. Med. 2012, 53:37-46.
13. Costa D.A., Cracchiolo J.R., Bachstetter A.D., Hughes T.F., Bales K.R., Paul S.M., Mervis R.F., et al. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol. Aging 2007, 28:831-844.
14. Cotel M.C., Jawhar S., Christensen D.Z., Bayer T.A., Wirths O. Environmental enrichment fails to rescue working memory deficits, neuron loss, and neurogenesis in APP/PS1KI mice. Neurobiol. Aging 2012, 33:96-107.
15. de Senna P.N., Ilha J., Baptista P.P., do Nascimento P.S., Leite M.C., Paim M.F., Goncalves C.A., et al. Effects of physical exercise on spatial memory and astroglial alterations in the hippocampus of diabetic rats. Metab. Brain Dis. 2011, 26:269-279.
16. Dickson D.W. Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies. Neurobiol. Aging 1997, 18:S21-S26.
17. Dutra M.F., Jaeger M., Ilha J., Kalil-Gaspar P.I., Marcuzzo S., Achaval M. Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson's disease. Neurol. Sci. 2012, 33(5):1137-1144.
18. Fuller S., Steele M., Munch G. Activated astroglia during chronic inflammation in Alzheimer's disease-do they neglect their neurosupportive roles?. Mutat. Res. 2010, 690:40-49.
19. Galvan V., Gorostiza O.F., Banwait S., Ataie M., Logvinova A.V., Sitaraman S., Carlson E., et al. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7130-7135.
20. Geinisman Y., Bondareff W., Dodge J.T. Hypertrophy of astroglial processes in the dentate gyrus of the senescent rat. Am. J. Anat. 1978, 153:537-543.
21. Giaume C., Kirchhoff F., Matute C., Reichenbach A., Verkhratsky A. Glia: the fulcrum of brain diseases. Cell Death Differ. 2007, 14:1324-1335.
22. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., Moller A., et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988, 96:857-881.
23. Hebb D.O. The effects of early experience on problem-solving at maturity. Am. Psychol. 1947, 2:306-307.
24. Heneka M.T., Rodriguez J.J., Verkhratsky A. Neuroglia in neurodegeneration. Brain Res. Rev. 2010, 63:189-211.
25. Herring A., Yasin H., Ambree O., Sachser N., Paulus W., Keyvani K. Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice. Brain Pathol. 2008, 18:32-39.
26. Hou L., Liu Y., Wang X., Ma H., He J., Zhang Y., Yu C., et al. The effects of amyloid-beta42 oligomer on the proliferation and activation of astrocytes in vitro. In Vitro Cell. Dev. Biol. Anim. 2011, 47:573-580.
27. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:3228-3233.
28. Jankowsky J.L., Xu G., Fromholt D., Gonzales V., Borchelt D.R. Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 2003, 62:1220-1227.
29. Jankowsky J.L., Melnikova T., Fadale D.J., Xu G.M., Slunt H.H., Gonzales V., Younkin L.H., et al. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J. Neurosci. 2005, 25:5217-5224.
30. Jinno S. Regional and laminar differences in antigen profiles and spatial distributions of astrocytes in the mouse hippocampus, with reference to aging. Neuroscience 2011, 180:41-52.
31. Kempermann G., Kuhn H., Gage F. More hippocampal neurons in adult mice living in an enriched environment. Nature 1997, 386:493-495.
32. Kempermann G., Kuhn H.G., Gage F.H. Experience-induced neurogenesis in the senescent dentate gyrus. J. Neurosci. 1998, 18:3206-3212.
33. Klein W.L., Krafft G.A., Finch C.E. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?. Trends Neurosci. 2001, 24:219-224.
34. Krause D.L., Muller N. Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int. J. Alzheimers Dis. 2010, pii:732806.
35. Krech D., Rosenzweig M.R., Bennett E.L. Relations between chemistry and problem-solving among rats raised in enriched and impoverished environments. J. Comp. Physiol. Psychol. 1962, 55:801-807.
36. Kuchibhotla K.V., Lattarulo C.R., Hyman B.T., Bacskai B.J. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 2009, 323:1211-1215.
37. Lazarov O., Robinson J., Tang Y.P., Hairston I.S., Korade-Mirnics Z., Lee V.M., Hersh L.B., et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005, 120:701-713.
38. Li S., Mallory M., Alford M., Tanaka S., Masliah E. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J. Neuropathol. Exp. Neurol. 1997, 56:901-911.
39. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 1999, 155:853-862.
40. Masliah E., Alford M., DeTeresa R., Mallory M., Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 1996, 40:759-766.
41. Massoud F., Leger G.C. Pharmacological treatment of Alzheimer disease. Can. J. Psychiatry 2011, 56:579-588.
42. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
43. Mayeux R. Clinical practice. Early Alzheimer's disease. N. Engl. J. Med. 2010, 362:2194-2201.
44. Mirochnic S., Wolf S., Staufenbiel M., Kempermann G. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease. Hippocampus 2009, 19:1008-1018.
45. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 2000, 20:4050-4058.
46. Mulder S.D., Veerhuis R., Blankenstein M.A., Nielsen H.M. The effect of amyloid associated proteins on the expression of genes involved in amyloid-beta clearance by adult human astrocytes. Exp. Neurol. 2012, 233:373-379.
47. Murphy S., Pearce B. Functional receptors for neurotransmitters on astroglial cells. Neuroscience 1987, 22:381-394.
48. Murray A.D., Staff R.T., McNeil C.J., Salarirad S., Ahearn T.S., Mustafa N., Whalley L.J. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases. Brain 2011, 134:3687-3696.
49. Nagele R.G., Wegiel J., Venkataraman V., Imaki H., Wang K.C., Wegiel J. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol. Aging 2004, 25:663-674.
50. Nedergaard M., Dirnagl U. Role of glial cells in cerebral ischemia. Glia 2005, 50:281-286.
51. Newman S.F., Sultana R., Perluigi M., Coccia R., Cai J., Pierce W.M., Klein J.B., et al. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach. J. Neurosci. Res. 2007, 85:1506-1514.
52. Nithianantharajah J., Hannan A.J. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 2006, 7:697-709.
53. Ohira K., Funatsu N., Homma K.J., Sahara Y., Hayashi M., Kaneko T., Nakamura S. Truncated TrkB-T1 regulates the morphology of neocortical layer I astrocytes in adult rat brain slices. Eur. J. Neurosci. 2007, 25:406-416.
54. Olabarria M., Noristani H.N., Verkhratsky A., Rodriguez J.J. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 2010, 58:831-838.
55. Olson A.K., Eadie B.D., Ernst C., Christie B.R. Environmental enrichment and voluntary exercise massively increase neurogenesis in the adult hippocampus via dissociable pathways. Hippocampus 2006, 16:250-260.
56. Parpura V., Verkhratsky A. Neuroglia at the crossroads of homeostasis, metabolism and signaling: evolution of the concept. ASN Neuro 2012, 4(4):201-205.
57. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
58. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N. Engl. J. Med. 2010, 362:329-344.
59. Raponi E., Agenes F., Delphin C., Assard N., Baudier J., Legraverend C., Deloulme J.C. S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage. Glia 2007, 55:165-177.
60. Roberson E.D., Scearce-Levie K., Palop J.J., Yan F., Cheng I.H., Wu T., Gerstein H., et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007, 316:750-754.
61. Rodriguez J.J., Olabarria M., Chvatal A., Verkhratsky A. Astroglia in dementia and Alzheimer's disease. Cell Death Differ. 2009, 16:378-385.
62. Rolyan H., Feike A.C., Upadhaya A.R., Waha A., Van Dooren T., Haass C., Birkenmeier G., et al. Amyloid-beta protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease. J. Neural Transm. 2011, 118:699-712.
63. Scheff S.W., Price D.A., Schmitt F.A., DeKosky S.T., Mufson E.J. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007, 68:1501-1508.
64. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N. Y. Acad. Sci. 2000, 924:17-25.
65. Sholl D.A. Dendritic organization in the neurons of the visual and motor cortices of the cat. J. Anat. 1953, 87:387-406.
66. Simpson J.E., Ince P.G., Shaw P.J., Heath P.R., Raman R., Garwood C.J., Gelsthorpe C., et al. Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype. Neurobiol. Aging 2011, 32:1795-1807.
67. Sirevaag A.M., Greenough W.T. Plasticity of GFAP-immunoreactive astrocyte size and number in visual cortex of rats reared in complex environments. Brain Res. 1991, 540:273-278.
68. Spilman P., Podlutskaya N., Hart M.J., Debnath J., Gorostiza O., Bredesen D., Richardson A., et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 2010, 5:e9979.
69. Steele M.L., Robinson S.R. Reactive astrocytes give neurons less support: implications for Alzheimer's disease. Neurobiol. Aging 2012, 33(2):423.e1-13.
70. Steiner B., Kronenberg G., Jessberger S., Brandt M.D., Reuter K., Kempermann G. Differential regulation of gliogenesis in the context of adult hippocampal neurogenesis in mice. Glia 2004, 46:41-52.
71. Thal D.R. The role of astrocytes in amyloid beta-protein toxicity and clearance. Exp. Neurol. 2012, 236:1-5.
72. Thal D.R., Schultz C., Dehghani F., Yamaguchi H., Braak H., Braak E. Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex. Acta Neuropathol. 2000, 100:608-617.
73. Tian G.F., Azmi H., Takano T., Xu Q., Peng W., Lin J., Oberheim N., et al. An astrocytic basis of epilepsy. Nat. Med. 2005, 11:973-981.
74. Tomiyama T., Matsuyama S., Iso H., Umeda T., Takuma H., Ohnishi K., Ishibashi K., et al. A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. J. Neurosci. 2010, 30:4845-4856.
75. Valero J., Espana J., Parra-Damas A., Martin E., Rodriguez-Alvarez J., Saura C.A. Short-term environmental enrichment rescues adult neurogenesis and memory deficits in APP(Sw, Ind) transgenic mice. PLoS One 2011, 6:e16832.
76. van Praag H., Kempermann G., Gage F.H. Neural consequences of environmental enrichment. Nat. Rev. Neurosci. 2000, 1:191-198.
77. Verret, L., Krezymon, A., Halley, H., Trouche, S., Zerwas, M., Lazouret, M., Lassalle, J.M., et al., in press. Transient enriched housing before amyloidosis onset sustains cogni-tive improvement in Tg2576 mice. Neurobiol Aging. (Electronic publication ahead of print). http://dx.doi.org/10.1016/j.neurobiolaging.2012.05.013.
78. Vijayan V.K., Geddes J.W., Anderson K.J., Chang-Chui H., Ellis W.G., Cotman C.W. Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation. Exp. Neurol. 1991, 112:72-78.
79. Viola G.G., Rodrigues L., Americo J.C., Hansel G., Vargas R.S., Biasibetti R., Swarowsky A., et al. Morphological changes in hippocampal astrocytes induced by environmental enrichment in mice. Brain Res. 2009, 1274:47-54.
80. Webster B., Hansen L., Adame A., Crews L., Torrance M., Thal L., Masliah E. Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006, 65:142-151.
81. Wilcock D.M., Gordon M.N., Morgan D. Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain. Nat. Protoc. 2006, 1:1591-1595.
82. Williamson L.L., Chao A., Bilbo S.D. Environmental enrichment alters glial antigen expression and neuroimmune function in the adult rat hippocampus. Brain Behav. Immun. 2012, 26:500-510.
83. Wyss-Coray T., Lin C., Yan F., Yu G.Q., Rohde M., McConlogue L., Masliah E., et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 2001, 7:612-618.
84. Yeh C.Y., Vadhwana B., Verkhratsky A., Rodriguez J.J. Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease. ASN Neuro 2011, 3:271-279.